Every 10-Q that Berto Acquisition Corp. (TACO) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow TACO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full TACO filings page.
Berto Acquisition Corp., a Cayman Islands SPAC, reports as of June 30, 2026 total assets of $314.4 million, almost all in a Trust Account holding $314.1 million of U.S. Treasury securities backing 30,015,000 redeemable public shares at $10.46 per share. Cash outside the trust was $146,740, with a working capital deficit of about $2.1 million.
For the six months ended June 30, 2026, the company generated net income of $3.3 million, driven by $5.4 million of investment income on trust assets, partially offset by $2.1 million of general and administrative expenses, including merger-related costs. No operating business has been acquired yet; a prior non-binding LOI with OnMed LLC expired on March 23, 2026. Management discloses that limited liquidity and the need to complete a business combination by May 1, 2027 create substantial doubt about the company’s ability to continue as a going concern.
Berto Acquisition Corp. reports first‑quarter 2026 results as a pre‑deal SPAC. Net income was approximately $2.2 million, driven almost entirely by $2.7 million of interest income on the $311.4 million held in its Trust Account, while general and administrative costs rose to about $482,000.
The company held only $209,000 of cash outside the Trust Account and had a working capital deficit of roughly $480,000. Management states that the mandatory liquidation deadline of May 1, 2027 if no Initial Business Combination is completed raises substantial doubt about its ability to continue as a going concern.
Berto Acquisition Corp. filed its quarterly report for the period ended September 30, 2025. The SPAC reported net income of $3.17 million for the quarter and $5.01 million year-to-date, driven primarily by interest earned on funds in its trust.
The company completed its IPO on May 1, 2025, selling 30,015,000 units at $10.00 for gross proceeds of $300.15 million, with approximately $17.8 million in offering costs, including $11.7 million of deferred underwriting commissions. As of September 30, 2025, the trust account held $305,577,225 (reflecting accretion to $10.18 per redeemable share). Cash held outside the trust was $325,010 with working capital of approximately $216,000.
There were 37,518,750 ordinary shares outstanding as of November 13, 2025, including 30,015,000 Public Shares and 7,503,750 Founder Shares. Warrants outstanding comprised 15,007,500 public, 3,500,000 sponsor private placement, and 3,750,000 underwriter warrants, with an exercise price of $10.50 in the first 12 months after a business combination and $11.50 thereafter. The completion window extends to May 1, 2027. On October 29, 2025, the company announced a non-binding LOI with OnMed LLC.